GE HealthCare Technologies Inc. $GEHC Stock Position Lowered by Intech Investment Management LLC

Intech Investment Management LLC lowered its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 86.8% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,448 shares of the company’s stock after selling 153,901 shares during the quarter. Intech Investment Management LLC’s holdings in GE HealthCare Technologies were worth $1,761,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Dodge & Cox lifted its holdings in GE HealthCare Technologies by 42.1% in the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after acquiring an additional 6,982,441 shares during the last quarter. Norges Bank acquired a new stake in GE HealthCare Technologies during the second quarter valued at approximately $468,120,000. Holocene Advisors LP boosted its holdings in GE HealthCare Technologies by 178.5% during the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after buying an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. acquired a new position in GE HealthCare Technologies in the second quarter worth approximately $80,755,000. Finally, Balyasny Asset Management L.P. bought a new position in shares of GE HealthCare Technologies in the second quarter valued at $58,388,000. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 2.4%

GEHC opened at $77.11 on Friday. The company has a market capitalization of $35.14 billion, a PE ratio of 16.91, a price-to-earnings-growth ratio of 1.74 and a beta of 1.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $89.77. The business has a 50-day moving average of $81.99 and a 200-day moving average of $78.53.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on GEHC shares. Barclays raised their price objective on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research note on Friday, February 6th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Piper Sandler upped their price objective on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, January 30th. Finally, Bank of America lifted their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research report on Monday, January 5th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $92.50.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.